EN
TR
Continuous Subcutaneous Insulin Infusion Therapy in Diabetic Pregnancies
Abstract
Aim: One of the ways to reach target blood sugar levels in diabetic pregnancies who need insulin therapy is multiple doses of insulin (MDI) injection and the other one is insulin pump which is provided by continuous subcutaneous insulin infusion (CSII). The aim of our study was to evaluate the results of two different insulin administration methods in our follow-up pregnant cases.Material and Methods: We retrospectively evaluated the data of maternal and fetal outcome points in pregnancy cases in our diabetes and pump outpatient clinics. 155 cases with type 1 Diabetes Mellitus (DM) who were followed in the diabetes clinic were screened about CSII and MDI injections.Results: In the CSII group, three (13.6%) pregnancies resulted in abortion and 19 cases (86.4%) gave birth to an average weight of 3516.3 ± 681.6 gr. Two (18.2%) pregnancies in the MDI injection group resulted in abortion and 9 cases (80.8%) gave birth to an average of 3411.7 ± 240.9 gr.Conclusion: Pregnant diabetics who need to use insulin can use either CSII or MDI injection. However, the quality of life of both the mother and the baby must be taken into account during pregnancy
Keywords
Details
Primary Language
English
Subjects
-
Journal Section
-
Publication Date
August 1, 2017
Submission Date
August 1, 2017
Acceptance Date
-
Published in Issue
Year 2017 Volume: 1 Number: 2
APA
Yıldırım Şimşir, I., Özkan Derviş, V., & Çetinkalp, Ş. (2017). Continuous Subcutaneous Insulin Infusion Therapy in Diabetic Pregnancies. Turkish Journal of Diabetes and Obesity, 1(2), 73-76. https://izlik.org/JA43PJ56KY
AMA
1.Yıldırım Şimşir I, Özkan Derviş V, Çetinkalp Ş. Continuous Subcutaneous Insulin Infusion Therapy in Diabetic Pregnancies. Turk J Diab Obes. 2017;1(2):73-76. https://izlik.org/JA43PJ56KY
Chicago
Yıldırım Şimşir, ILGIN, VİLDAN Özkan Derviş, and ŞEVKİ Çetinkalp. 2017. “Continuous Subcutaneous Insulin Infusion Therapy in Diabetic Pregnancies”. Turkish Journal of Diabetes and Obesity 1 (2): 73-76. https://izlik.org/JA43PJ56KY.
EndNote
Yıldırım Şimşir I, Özkan Derviş V, Çetinkalp Ş (August 1, 2017) Continuous Subcutaneous Insulin Infusion Therapy in Diabetic Pregnancies. Turkish Journal of Diabetes and Obesity 1 2 73–76.
IEEE
[1]I. Yıldırım Şimşir, V. Özkan Derviş, and Ş. Çetinkalp, “Continuous Subcutaneous Insulin Infusion Therapy in Diabetic Pregnancies”, Turk J Diab Obes, vol. 1, no. 2, pp. 73–76, Aug. 2017, [Online]. Available: https://izlik.org/JA43PJ56KY
ISNAD
Yıldırım Şimşir, ILGIN - Özkan Derviş, VİLDAN - Çetinkalp, ŞEVKİ. “Continuous Subcutaneous Insulin Infusion Therapy in Diabetic Pregnancies”. Turkish Journal of Diabetes and Obesity 1/2 (August 1, 2017): 73-76. https://izlik.org/JA43PJ56KY.
JAMA
1.Yıldırım Şimşir I, Özkan Derviş V, Çetinkalp Ş. Continuous Subcutaneous Insulin Infusion Therapy in Diabetic Pregnancies. Turk J Diab Obes. 2017;1:73–76.
MLA
Yıldırım Şimşir, ILGIN, et al. “Continuous Subcutaneous Insulin Infusion Therapy in Diabetic Pregnancies”. Turkish Journal of Diabetes and Obesity, vol. 1, no. 2, Aug. 2017, pp. 73-76, https://izlik.org/JA43PJ56KY.
Vancouver
1.ILGIN Yıldırım Şimşir, VİLDAN Özkan Derviş, ŞEVKİ Çetinkalp. Continuous Subcutaneous Insulin Infusion Therapy in Diabetic Pregnancies. Turk J Diab Obes [Internet]. 2017 Aug. 1;1(2):73-6. Available from: https://izlik.org/JA43PJ56KY